who should not take glp 1 receptor agonists Your guide to GLP-1 side effects GLP-1 Receptor Agonists in Solid
Description
Interestingly, research on vildagliptin indicates that DPP4 inhibition may also improve insulin sensitivity in type 2 diabetes, as shown through indirect assessments of insulin sensitivity [52] and the hyperinsulinemic euglycemic clamp test [60]
Broeders M, Velseboer DC, de Bie R, Speelman JD, Muslimovic D, Post B, et al
To reinforce the reliability of primary analyses, external validation was performed using data from the Chang Gung Research Database (CGRD) 55
Two converging reasons
Due to DPP-4 and renal clearance, native GLP-1 in humans has a half-life of about 1-2 minutes (89)
